- Open
- 21.50
- High
- 23.96
- Low
- 21.00
- Close
- 23.40
- Change
- +0.50 (2.33%)
- Volume
- 726,254
⌘K
| 22 Jun 2026 | 09:40:15 | Publication of Phase 1 data on SDC-1801 in BJCP |
| 1 May 2026 | 07:00:05 | Exercise of Warrants |
| 12 Mar 2026 | 07:00:09 | Half-Year Report for Six Months Ended 31 Dec 2025 |
| 3 Mar 2026 | 07:00:09 | Notice of Results and Investor Presentation |
| 23 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 31 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 31 Dec 2023 | Annual Report and Accounts (to 2023-06-30) |
Sareum is a company that focuses on developing drugs that are specifically designed to treat cancer and autoimmune diseases using small molecules.
| 22 Jun 2026 | 09:40:15 | Publication of Phase 1 data on SDC-1801 in BJCP |
| 1 May 2026 | 07:00:05 | Exercise of Warrants |
| 12 Mar 2026 | 07:00:09 | Half-Year Report for Six Months Ended 31 Dec 2025 |
| 3 Mar 2026 | 07:00:09 | Notice of Results and Investor Presentation |
| 23 Dec 2025 | Annual Report and Accounts (to 2025-06-30) | |
| 31 Dec 2024 | Annual Report and Accounts (to 2024-06-30) | |
| 31 Dec 2023 | Annual Report and Accounts (to 2023-06-30) |
Sareum is a company that focuses on developing drugs that are specifically designed to treat cancer and autoimmune diseases using small molecules.
| 17 Feb 2026 | 07:00:09 | Restart of Phase 2-enabling toxicology programme |
| 10 Oct 2025 |
| AIM movers: Genedrive stake increase and WH Ireland continues to fall |
| 13 Aug 2025 | Sareum Holdings — New collaboration cements focus on CNS |
| 3 Jun 2025 | Sareum Holdings — A decisive step towards Phase II |
| 10 Apr 2025 | Sareum Holdings — Broader pipeline, bigger milestones |
| 14 Mar 2025 | Sareum Holdings — New fund-raise and licence signal active 2025 |
| 17 Feb 2026 | 07:00:09 | Restart of Phase 2-enabling toxicology programme |
| 10 Oct 2025 |
| AIM movers: Genedrive stake increase and WH Ireland continues to fall |
| 13 Aug 2025 | Sareum Holdings — New collaboration cements focus on CNS |
| 3 Jun 2025 | Sareum Holdings — A decisive step towards Phase II |
| 10 Apr 2025 | Sareum Holdings — Broader pipeline, bigger milestones |
| 14 Mar 2025 | Sareum Holdings — New fund-raise and licence signal active 2025 |
